Editorial
Copyright ©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Radiol. Jun 28, 2012; 4(6): 241-246
Published online Jun 28, 2012. doi: 10.4329/wjr.v4.i6.241
Epidemiology of prostate cancer and treatment remarks
Stefano Arcangeli, Valentina Pinzi, Giorgio Arcangeli
Stefano Arcangeli, Valentina Pinzi, Giorgio Arcangeli, Department of Radiotherapy, Regina Elena National Cancer Institute, 00144 Rome, Italy
Author contributions: Arcangeli S and Pinzi V brought substantial contributions to conception and design of the study, acquisition of data, analysis and interpretation of data; Arcangeli G drafted the article and revised it critically; all authors declare no conflicts of interest.
Correspondence to: Stefano Arcangeli, MD, Department of Radiotherapy, Regina Elena National Cancer Institute, 00144 Rome, Italy. stefano.arcangeli@yahoo.it
Telephone: +39-6-52666131 Fax: +39-6-52663028
Received: February 14, 2011
Revised: June 15, 2012
Accepted: June 22, 2012
Published online: June 28, 2012
Abstract

Prostate cancer is one of the most common types of cancer and one of the leading causes of cancer death among men in the Western countries. The aim of the present analysis is to assess the cancer burden in order to ensure accurate strategies for chemoprevention and treatment, including the major therapeutic approaches for localized high-risk disease - surgery and radiation therapy - and quality of life issues related to each option.

Keywords: Prostate cancer; Epidemiology; Chemoprevention; Radiotherapy